Recruitment And Diversity
-
Patient Input Is A Must — Even Under Time And Money Constraints
12/4/2025
Stacie J. Bell, PhD, chief clinical research officer of Lupus Therapeutics, discusses the positive impacts patient advocacy groups can have on patient recruitment, patient retention, protocol design, and more.
-
Digital Biomarkers Are Reshaping Alzheimer's Patient Experience And Data
11/26/2025
Cognito CEO Christian Howell shares how EEG and digital biomarkers are reshaping recruitment, patient experience, and the quality of study data in Alzheimer’s research.
-
'ONE In A MILLION' Aims To Bridge The Equity Gap In Clinical Trials
11/20/2025
Tigerlily Foundation is launching its "ONE in a MILLION" national public-private partnership to engage one million people in high-risk communities with clinical research.
-
New Initiative Helps Researchers Enroll Healthy Volunteers In High Impact Trials
11/17/2025
1Day Sooner’s Director of Clinical Trials Circe MacDonald talks about their new Cooperative Patient Organization, the recruitment gaps it hopes to fill, and the importance of incorporating participant input.
-
Non-Invasive Brain-Computer Interface Trial Balances Regulatory Requirements With Patient Needs
11/13/2025
Cognixion CTO Chris Ullrich introduces the Axon-R Nucleus bio-sensing hub and discusses its feasibility trial, highlighting the importance of patient input, caregiver quality of life, and regulatory support.
-
Participant Recruitment In LMIC Clinical Trials
11/5/2025
Due to the high burden of infectious diseases in low- and middle-income countries (LMICs), there is greater urgency for vaccine trials. Participant recruitment entails significant work with communities.
-
Behavior Modeling Can Help Sponsors Better Understand Sites And Patients
11/4/2025
Learn how behavioral modeling can identify patients at risk of dropout and sites that may need additional support, so you can build a more resilient research network.
-
How AI Is Transforming Patient Stratification
10/31/2025
Discover how AI tools can help stratify or group patients into subtypes that respond differently to treatment.
-
Continuous Evidence Generation — Including RWE — Remains Critical To Vaccine Development
10/23/2025
President of Takeda's Global Vaccine Business Unit Derek Wallace discusses the importance of continuous, real-world data collection in the context of vaccine development in low- and middle-income countries.
-
How Redefining The Diagnostic Odyssey Can Lead To Better Patient Outcomes
10/22/2025
Patient advocate Wendy Cogan calls for improved diagnostic pathways as a means to better clinical trial recruitment and design while telling the journey of her late husband's journey to a corticobasal degeneration(CBD)-frontal behavioral-spatial syndrome (FBS) diagnosis.